SE7500130L - - Google Patents

Info

Publication number
SE7500130L
SE7500130L SE7500130A SE7500130A SE7500130L SE 7500130 L SE7500130 L SE 7500130L SE 7500130 A SE7500130 A SE 7500130A SE 7500130 A SE7500130 A SE 7500130A SE 7500130 L SE7500130 L SE 7500130L
Authority
SE
Sweden
Prior art keywords
influenza
components
virus
type
cationic detergent
Prior art date
Application number
SE7500130A
Other languages
Unknown language ( )
English (en)
Other versions
SE427238B (sv
Inventor
H Bachmayer
G Schmidth
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of SE7500130L publication Critical patent/SE7500130L/
Publication of SE427238B publication Critical patent/SE427238B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/145Orthomyxoviridae, e.g. influenza virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5252Virus inactivated (killed)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16111Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16211Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Detergent Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
SE7500130A 1974-01-14 1975-01-07 Sett att isolera influensavirus-subenheter SE427238B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH44774A CH589453A5 (cs) 1974-01-14 1974-01-14

Publications (2)

Publication Number Publication Date
SE7500130L true SE7500130L (cs) 1975-07-15
SE427238B SE427238B (sv) 1983-03-21

Family

ID=4187233

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7500130A SE427238B (sv) 1974-01-14 1975-01-07 Sett att isolera influensavirus-subenheter

Country Status (27)

Country Link
JP (2) JPS58407B2 (cs)
AT (1) AT345449B (cs)
AU (1) AU500250B2 (cs)
BE (1) BE824372A (cs)
CA (1) CA1049406A (cs)
CH (1) CH589453A5 (cs)
CS (1) CS191254B2 (cs)
DD (1) DD116239A5 (cs)
DE (1) DE2500785B2 (cs)
DK (1) DK140003B (cs)
ES (1) ES433759A1 (cs)
FI (1) FI54053C (cs)
FR (1) FR2257305B1 (cs)
GB (1) GB1498261A (cs)
HK (1) HK56380A (cs)
HU (1) HU173920B (cs)
IE (1) IE40794B1 (cs)
IL (1) IL46426A (cs)
MY (1) MY8100204A (cs)
NL (1) NL166622C (cs)
NO (1) NO143128C (cs)
PH (1) PH14458A (cs)
PL (1) PL93689B1 (cs)
SE (1) SE427238B (cs)
SU (1) SU616997A3 (cs)
YU (1) YU41289B (cs)
ZA (1) ZA75259B (cs)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2829089A1 (de) * 1977-07-13 1979-02-01 Sandoz Ag Subunit-vakzine
JPH0688911B2 (ja) * 1985-06-06 1994-11-09 国立予防衛生研究所長 インフルエンザワクチン及びその製造方法
TW570803B (en) * 1997-04-09 2004-01-11 Duphar Int Res Influenza vaccine
EP0919243A1 (en) 1997-11-25 1999-06-02 Duphar International Research B.V Vaccine containing B subunits of heat-labile enterotoxin (LTB) of Escherichia coli as an adjuvant
DE19938767C2 (de) * 1999-08-16 2002-10-24 Tad Pharma Gmbh Spaltimpfstoffe
PL1951296T5 (pl) * 2005-11-01 2015-06-30 Seqirus Uk Ltd Szczepionki wirusowe otrzymane z komórek o niskim poziomie pozostałości DNA komórkowego poprzez traktowanie beta-propiolaktonem
SI2192917T1 (sl) * 2007-08-28 2014-05-30 Baxter International Inc. Postopek za proizvodnjo virusnih cepiv
WO2015071177A1 (en) 2013-11-15 2015-05-21 Novartis Ag Removal of residual cell culture impurities

Also Published As

Publication number Publication date
CA1049406A (en) 1979-02-27
DK1475A (cs) 1975-09-01
SE427238B (sv) 1983-03-21
HU173920B (hu) 1979-09-28
PH14458A (en) 1981-07-29
DE2500785B2 (de) 1980-01-03
IL46426A0 (en) 1975-04-25
FI750014A7 (cs) 1975-07-15
CH589453A5 (cs) 1977-07-15
NO143128B (no) 1980-09-15
JPS50100224A (cs) 1975-08-08
IE40794L (en) 1975-07-14
DK140003C (cs) 1979-10-29
AU500250B2 (en) 1979-05-17
CS191254B2 (en) 1979-06-29
FI54053B (fi) 1978-06-30
JPS6035326B2 (ja) 1985-08-14
PL93689B1 (cs) 1977-06-30
ES433759A1 (es) 1977-02-16
NO143128C (no) 1980-12-29
DE2500785A1 (de) 1975-07-31
NL166622B (nl) 1981-04-15
FI54053C (fi) 1978-10-10
AT345449B (de) 1978-09-11
JPS58407B2 (ja) 1983-01-06
AU7730575A (en) 1976-07-15
DE2500785C3 (cs) 1980-09-11
MY8100204A (en) 1981-12-31
GB1498261A (en) 1978-01-18
IE40794B1 (en) 1979-08-15
NO750031L (cs) 1975-08-11
DD116239A5 (cs) 1975-11-12
FR2257305A1 (cs) 1975-08-08
FR2257305B1 (cs) 1982-03-19
BE824372A (fr) 1975-07-14
ATA21475A (de) 1978-01-15
HK56380A (en) 1980-10-16
YU5875A (en) 1984-04-30
JPS56127319A (en) 1981-10-06
IL46426A (en) 1978-01-31
SU616997A3 (ru) 1978-07-25
DK140003B (da) 1979-06-05
YU41289B (en) 1987-02-28
NL166622C (nl) 1981-09-15
ZA75259B (en) 1976-08-25
NL7500301A (nl) 1975-07-16

Similar Documents

Publication Publication Date Title
Cella et al. Maturation, activation, and protection of dendritic cells induced by double-stranded RNA
Bevan et al. Cytotoxic effects of antigen-and mitogen-induced T cells on various targets
HU9401056D0 (en) Porcine reproductive respiratory syndrome vaccine and diagnostic
BR9106374A (pt) Vacina oral e processo de extrair uma imunoresponsta em um mamifero
SE7500130L (cs)
Hirst et al. A new method for concentrating influenza virus from allantoic fluid
Bang Filamentous forms of Newcastle virus
Russell et al. Cell cooperation in antibody responses to influenza virus. I. Priming of helper T cells by internal components of the virion
ES8104405A1 (es) Procedimiento para preparar una vacuna de virus de gripe
PH12022550939A1 (en) Chikungunya virus-like particle vaccine and methods of using the same
GB2001326A (en) Glycoproteins from paramyxovirus and vaccines therefrom
GB1461188A (en) Live influenza virus vaccines and preparation thereof
GB1488800A (en) Influenza vaccines
ES379642A1 (es) Procedimiento para la obtencion de vacunas perfeccionadas.
AU5573196A (en) A pluripotent vaccine against enveloped viruses
GB1140316A (en) Influenza virus sub-unit vaccine
GB953992A (en) Vaccine products and method of preparing same
CA1270438A (en) Influenza vaccine
GB1434181A (en) Vaccine for the prevention and treatment of vascular conditions
GB1413401A (en) Influenza vaccine
郭元吉 et al. Influenza C virus isolated from pigs in China
PT100460A (pt) Partiiculas derivadas de virus de herpes e vacinas que as contem
Coggins et al. Serological Comparison with Rabbit Antisera of Hog Cholera Virus and Bovine Virus Diarrhea Virus.
WO2024186901A3 (en) Broadly reactive immunogens of influenza h3 virus, compositions and methods of use thereof
AR120296A1 (es) Vacuna de partículas de virus de tipo chikungunya y sus métodos de uso

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7500130-5

Effective date: 19940810

Format of ref document f/p: F